nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—CYP3A4—bone cancer	0.563	1	CbGaD
Flunitrazepam—UGT2B7—Epirubicin—bone cancer	0.198	0.611	CbGbCtD
Flunitrazepam—CYP2B6—Cisplatin—bone cancer	0.0525	0.162	CbGbCtD
Flunitrazepam—CYP2B6—Doxorubicin—bone cancer	0.0352	0.108	CbGbCtD
Flunitrazepam—CYP2C9—Cisplatin—bone cancer	0.0277	0.0855	CbGbCtD
Flunitrazepam—CYP3A4—Doxorubicin—bone cancer	0.0108	0.0333	CbGbCtD
Flunitrazepam—Acenocoumarol—CYP3A4—bone cancer	0.000913	0.151	CrCbGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000734	0.00691	CbGpPWpGaD
Flunitrazepam—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000729	0.00687	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000719	0.00677	CbGpPWpGaD
Flunitrazepam—GABRA5—Orphan transporters—TUBB2A—bone cancer	0.000713	0.00671	CbGpPWpGaD
Flunitrazepam—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000701	0.0066	CbGpPWpGaD
Flunitrazepam—GABRA3—Orphan transporters—TUBB2A—bone cancer	0.0007	0.00659	CbGpPWpGaD
Flunitrazepam—GABRA2—Orphan transporters—TUBB2A—bone cancer	0.000688	0.00648	CbGpPWpGaD
Flunitrazepam—GABRA1—Orphan transporters—TUBB4B—bone cancer	0.00068	0.0064	CbGpPWpGaD
Flunitrazepam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000635	0.00598	CbGpPWpGaD
Flunitrazepam—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000622	0.00586	CbGpPWpGaD
Flunitrazepam—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000598	0.00563	CbGpPWpGaD
Flunitrazepam—GABRA1—Orphan transporters—TUBB2A—bone cancer	0.000587	0.00553	CbGpPWpGaD
Flunitrazepam—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00058	0.00546	CbGpPWpGaD
Flunitrazepam—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000567	0.00534	CbGpPWpGaD
Flunitrazepam—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000565	0.00532	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000555	0.00522	CbGpPWpGaD
Flunitrazepam—Ketazolam—CYP3A4—bone cancer	0.000547	0.0903	CrCbGaD
Flunitrazepam—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000546	0.00514	CbGpPWpGaD
Flunitrazepam—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000543	0.00511	CbGpPWpGaD
Flunitrazepam—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.000541	0.00509	CbGpPWpGaD
Flunitrazepam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000539	0.00507	CbGpPWpGaD
Flunitrazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000527	0.00497	CbGpPWpGaD
Flunitrazepam—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000527	0.00497	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000506	0.00476	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000505	0.00476	CbGpPWpGaD
Flunitrazepam—UGT1A3—Phase II conjugation—GSTP1—bone cancer	0.000501	0.00472	CbGpPWpGaD
Flunitrazepam—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000487	0.00459	CbGpPWpGaD
Flunitrazepam—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000485	0.00456	CbGpPWpGaD
Flunitrazepam—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000466	0.00439	CbGpPWpGaD
Flunitrazepam—Clonazepam—CYP3A4—bone cancer	0.000441	0.0728	CrCbGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000432	0.00407	CbGpPWpGaD
Flunitrazepam—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000427	0.00402	CbGpPWpGaD
Flunitrazepam—UGT2B7—Phase II conjugation—GSTP1—bone cancer	0.000426	0.00401	CbGpPWpGaD
Flunitrazepam—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000424	0.00399	CbGpPWpGaD
Flunitrazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000419	0.00394	CbGpPWpGaD
Flunitrazepam—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000418	0.00394	CbGpPWpGaD
Flunitrazepam—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000414	0.0039	CbGpPWpGaD
Flunitrazepam—Clotiazepam—CYP3A4—bone cancer	0.000409	0.0676	CrCbGaD
Flunitrazepam—UGT1A3—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000393	0.0037	CbGpPWpGaD
Flunitrazepam—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00039	0.00367	CbGpPWpGaD
Flunitrazepam—Clobazam—CYP3A4—bone cancer	0.000386	0.0638	CrCbGaD
Flunitrazepam—Alprazolam—CYP3A4—bone cancer	0.000386	0.0638	CrCbGaD
Flunitrazepam—Quazepam—CYP3A4—bone cancer	0.000375	0.0619	CrCbGaD
Flunitrazepam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000371	0.00349	CbGpPWpGaD
Flunitrazepam—UGT1A1—Phase II conjugation—GSTP1—bone cancer	0.000346	0.00326	CbGpPWpGaD
Flunitrazepam—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000344	0.00323	CbGpPWpGaD
Flunitrazepam—UGT1A3—Biological oxidations—CYP3A4—bone cancer	0.000343	0.00323	CbGpPWpGaD
Flunitrazepam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000342	0.00322	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metapathway biotransformation—CYP3A4—bone cancer	0.000338	0.00318	CbGpPWpGaD
Flunitrazepam—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000337	0.00318	CbGpPWpGaD
Flunitrazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000335	0.00315	CbGpPWpGaD
Flunitrazepam—UGT1A3—NRF2 pathway—GSTP1—bone cancer	0.000334	0.00315	CbGpPWpGaD
Flunitrazepam—UGT1A3—NRF2 pathway—TGFBR2—bone cancer	0.000334	0.00315	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000334	0.00314	CbGpPWpGaD
Flunitrazepam—Estazolam—CYP3A4—bone cancer	0.000331	0.0547	CrCbGaD
Flunitrazepam—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00033	0.00311	CbGpPWpGaD
Flunitrazepam—Nitrazepam—CYP3A4—bone cancer	0.000319	0.0528	CrCbGaD
Flunitrazepam—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000317	0.00299	CbGpPWpGaD
Flunitrazepam—Adinazolam—CYP3A4—bone cancer	0.000315	0.052	CrCbGaD
Flunitrazepam—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000309	0.00291	CbGpPWpGaD
Flunitrazepam—Prazepam—CYP3A4—bone cancer	0.000305	0.0503	CrCbGaD
Flunitrazepam—UGT1A3—Biological oxidations—GSTP1—bone cancer	0.000293	0.00276	CbGpPWpGaD
Flunitrazepam—UGT2B7—Biological oxidations—CYP3A4—bone cancer	0.000291	0.00274	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metapathway biotransformation—GSTP1—bone cancer	0.000289	0.00272	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metapathway biotransformation—CYP3A4—bone cancer	0.000287	0.0027	CbGpPWpGaD
Flunitrazepam—UGT2B7—NRF2 pathway—TGFBR2—bone cancer	0.000284	0.00267	CbGpPWpGaD
Flunitrazepam—UGT2B7—NRF2 pathway—GSTP1—bone cancer	0.000284	0.00267	CbGpPWpGaD
Flunitrazepam—Flurazepam—CYP3A4—bone cancer	0.000284	0.0469	CrCbGaD
Flunitrazepam—Triazolam—CYP3A4—bone cancer	0.000284	0.0468	CrCbGaD
Flunitrazepam—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000277	0.00261	CbGpPWpGaD
Flunitrazepam—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000273	0.00257	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000272	0.00256	CbGpPWpGaD
Flunitrazepam—Temazepam—CYP3A4—bone cancer	0.000272	0.0448	CrCbGaD
Flunitrazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000271	0.00256	CbGpPWpGaD
Flunitrazepam—Midazolam—CYP3A4—bone cancer	0.000263	0.0435	CrCbGaD
Flunitrazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000258	0.00243	CbGpPWpGaD
Flunitrazepam—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000255	0.0024	CbGpPWpGaD
Flunitrazepam—UGT2B7—Biological oxidations—GSTP1—bone cancer	0.000249	0.00235	CbGpPWpGaD
Flunitrazepam—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000249	0.00234	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metapathway biotransformation—GSTP1—bone cancer	0.000246	0.00231	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—CYP3A4—bone cancer	0.000237	0.00223	CbGpPWpGaD
Flunitrazepam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000236	0.00222	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000233	0.0022	CbGpPWpGaD
Flunitrazepam—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000232	0.00219	CbGpPWpGaD
Flunitrazepam—UGT1A1—NRF2 pathway—GSTP1—bone cancer	0.000231	0.00217	CbGpPWpGaD
Flunitrazepam—UGT1A1—NRF2 pathway—TGFBR2—bone cancer	0.000231	0.00217	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00023	0.00216	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000227	0.00214	CbGpPWpGaD
Flunitrazepam—Diazepam—CYP3A4—bone cancer	0.000226	0.0373	CrCbGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000214	0.00201	CbGpPWpGaD
Flunitrazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000209	0.00197	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—NDUFA12—bone cancer	0.000205	0.00193	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—GSTP1—bone cancer	0.000202	0.00191	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000202	0.0019	CbGpPWpGaD
Flunitrazepam—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000201	0.0019	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metapathway biotransformation—GSTP1—bone cancer	0.0002	0.00188	CbGpPWpGaD
Flunitrazepam—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000199	0.00187	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000198	0.00187	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000198	0.00186	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000196	0.00184	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000195	0.00183	CbGpPWpGaD
Flunitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000194	0.00183	CbGpPWpGaD
Flunitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000191	0.0018	CbGpPWpGaD
Flunitrazepam—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000191	0.0018	CbGpPWpGaD
Flunitrazepam—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.00019	0.00179	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000182	0.00172	CbGpPWpGaD
Flunitrazepam—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.00018	0.0017	CbGpPWpGaD
Flunitrazepam—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000178	0.00168	CbGpPWpGaD
Flunitrazepam—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000178	0.00168	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—NDUFA12—bone cancer	0.000175	0.00164	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000174	0.00164	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000171	0.00161	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—NT5C3A—bone cancer	0.00017	0.0016	CbGpPWpGaD
Flunitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00017	0.0016	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000168	0.00158	CbGpPWpGaD
Flunitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000167	0.00157	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000166	0.00156	CbGpPWpGaD
Flunitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000164	0.00155	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000163	0.00154	CbGpPWpGaD
Flunitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000163	0.00153	CbGpPWpGaD
Flunitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.00016	0.00151	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000156	0.00147	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000147	0.00139	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—BRAF—bone cancer	0.000146	0.00137	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000145	0.00137	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—NT5C3A—bone cancer	0.000145	0.00136	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000144	0.00136	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—BRAF—bone cancer	0.000144	0.00136	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000143	0.00135	CbGpPWpGaD
Flunitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000143	0.00134	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000142	0.00134	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—NDUFA12—bone cancer	0.000142	0.00134	CbGpPWpGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00014	0.00132	CbGpPWpGaD
Flunitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.00014	0.00132	CbGpPWpGaD
Flunitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000138	0.0013	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000134	0.00126	CbGpPWpGaD
Flunitrazepam—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000132	0.00125	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—BRAF—bone cancer	0.000128	0.0012	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000127	0.00119	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000126	0.00119	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000126	0.00118	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000124	0.00117	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000123	0.00116	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000123	0.00116	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—MDM2—bone cancer	0.000122	0.00115	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000122	0.00115	CbGpPWpGaD
Flunitrazepam—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000121	0.00114	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—MDM2—bone cancer	0.000121	0.00114	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—NT5C3A—bone cancer	0.000118	0.00111	CbGpPWpGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000117	0.0011	CbGpPWpGaD
Flunitrazepam—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000114	0.00108	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—BRAF—bone cancer	0.000112	0.00105	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000111	0.00105	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.00011	0.00104	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—BRAF—bone cancer	0.00011	0.00104	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.00011	0.00103	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—NDUFA12—bone cancer	0.000109	0.00103	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—MDM2—bone cancer	0.000107	0.00101	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000105	0.000991	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—MDM2—bone cancer	0.000105	0.000991	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000103	0.000974	CbGpPWpGaD
Flunitrazepam—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000103	0.000972	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—CYP3A4—bone cancer	0.000101	0.000955	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	0.0001	0.000942	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	9.95e-05	0.000936	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—BRAF—bone cancer	9.8e-05	0.000923	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—BRAF—bone cancer	9.62e-05	0.000906	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—GSTP1—bone cancer	9.52e-05	0.000896	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—BRAF—bone cancer	9.46e-05	0.00089	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	9.38e-05	0.000884	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—MDM2—bone cancer	9.36e-05	0.000881	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	9.35e-05	0.00088	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—MDM2—bone cancer	9.24e-05	0.00087	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—NT5C3A—bone cancer	9.06e-05	0.000853	CbGpPWpGaD
Flunitrazepam—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.83e-05	0.000832	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—NDUFA12—bone cancer	8.82e-05	0.000831	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	8.82e-05	0.00083	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—GSTP1—bone cancer	8.68e-05	0.000817	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—CYP3A4—bone cancer	8.67e-05	0.000816	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—NDUFA12—bone cancer	8.64e-05	0.000814	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	8.56e-05	0.000806	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	8.55e-05	0.000805	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—MDM2—bone cancer	8.21e-05	0.000773	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—BRAF—bone cancer	8.07e-05	0.000759	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—MDM2—bone cancer	8.06e-05	0.000759	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—MDM2—bone cancer	7.92e-05	0.000746	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	7.82e-05	0.000736	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	7.82e-05	0.000736	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—ENO2—bone cancer	7.45e-05	0.000702	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—GSTP1—bone cancer	7.41e-05	0.000698	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—NT5C3A—bone cancer	7.31e-05	0.000688	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	7.31e-05	0.000688	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—NT5C3A—bone cancer	7.16e-05	0.000674	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—DHFR—bone cancer	6.91e-05	0.000651	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—MDM2—bone cancer	6.76e-05	0.000636	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NDUFA12—bone cancer	6.67e-05	0.000628	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GNA11—bone cancer	6.46e-05	0.000608	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ENO2—bone cancer	6.34e-05	0.000597	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NDUFA12—bone cancer	6.08e-05	0.000572	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—DHFR—bone cancer	5.88e-05	0.000554	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CYP3A4—bone cancer	5.86e-05	0.000552	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.72e-05	0.000539	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.64e-05	0.000531	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NT5C3A—bone cancer	5.53e-05	0.00052	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GNA11—bone cancer	5.49e-05	0.000517	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NDUFA12—bone cancer	5.2e-05	0.000489	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ENO2—bone cancer	5.15e-05	0.000485	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NT5C3A—bone cancer	5.04e-05	0.000474	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GSTP1—bone cancer	5.01e-05	0.000472	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CYP3A4—bone cancer	4.98e-05	0.000469	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—DHFR—bone cancer	4.78e-05	0.00045	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GNA11—bone cancer	4.47e-05	0.00042	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NT5C3A—bone cancer	4.31e-05	0.000405	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GSTP1—bone cancer	4.26e-05	0.000401	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CYP3A4—bone cancer	4.05e-05	0.000381	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NDUFA12—bone cancer	4.01e-05	0.000378	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ENO2—bone cancer	3.97e-05	0.000374	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—DHFR—bone cancer	3.68e-05	0.000347	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GSTP1—bone cancer	3.46e-05	0.000326	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GNA11—bone cancer	3.44e-05	0.000324	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NT5C3A—bone cancer	3.32e-05	0.000313	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ENO2—bone cancer	3.2e-05	0.000302	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ENO2—bone cancer	3.14e-05	0.000295	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP3A4—bone cancer	3.12e-05	0.000294	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—DHFR—bone cancer	2.97e-05	0.00028	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—DHFR—bone cancer	2.91e-05	0.000274	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GNA11—bone cancer	2.78e-05	0.000261	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GNA11—bone cancer	2.72e-05	0.000256	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GSTP1—bone cancer	2.67e-05	0.000251	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PTGS2—bone cancer	2.6e-05	0.000244	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP3A4—bone cancer	2.52e-05	0.000237	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP3A4—bone cancer	2.47e-05	0.000232	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ENO2—bone cancer	2.42e-05	0.000228	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—DHFR—bone cancer	2.25e-05	0.000211	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTGS2—bone cancer	2.21e-05	0.000208	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ENO2—bone cancer	2.21e-05	0.000208	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTP1—bone cancer	2.15e-05	0.000203	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTP1—bone cancer	2.11e-05	0.000199	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GNA11—bone cancer	2.1e-05	0.000198	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—DHFR—bone cancer	2.05e-05	0.000193	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GNA11—bone cancer	1.91e-05	0.00018	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP3A4—bone cancer	1.9e-05	0.000179	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.89e-05	0.000178	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ENO2—bone cancer	1.89e-05	0.000178	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTGS2—bone cancer	1.79e-05	0.000169	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—DHFR—bone cancer	1.75e-05	0.000165	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP3A4—bone cancer	1.73e-05	0.000163	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.73e-05	0.000163	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GNA11—bone cancer	1.64e-05	0.000154	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTP1—bone cancer	1.63e-05	0.000153	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTP1—bone cancer	1.48e-05	0.00014	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP3A4—bone cancer	1.48e-05	0.00014	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.47e-05	0.000139	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ENO2—bone cancer	1.46e-05	0.000137	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTGS2—bone cancer	1.38e-05	0.00013	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—DHFR—bone cancer	1.35e-05	0.000127	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTP1—bone cancer	1.27e-05	0.000119	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GNA11—bone cancer	1.26e-05	0.000119	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTGS2—bone cancer	1.12e-05	0.000105	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTGS2—bone cancer	1.09e-05	0.000103	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTP1—bone cancer	9.79e-06	9.21e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTGS2—bone cancer	8.43e-06	7.94e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTGS2—bone cancer	7.69e-06	7.24e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTGS2—bone cancer	6.57e-06	6.18e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTGS2—bone cancer	5.07e-06	4.77e-05	CbGpPWpGaD
